Clinical trials
Status Epilepticus trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 9 |
| Terminated | 4 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Boston Medical Center | 2 |
| University of Twente | 2 |
| Xuanwu Hospital, Beijing | 2 |
| All India Institute of Medical Sciences | 1 |
| Ankara University | 1 |
| Baptist Health South Florida | 1 |
| Barts & The London NHS Trust | 1 |
| Boston Children's Hospital | 1 |
| Faculdade de Motricidade Humana | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Status Epilepticus | 30 |
| Epilepsy | 7 |
| Seizures | 4 |
| Heart Arrest | 3 |
| Coma | 2 |
| Epilepsia Partialis Continua | 2 |
| Anaphylaxis | 1 |
| Autoimmune Diseases | 1 |
| Brain Diseases | 1 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.